Drugs
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Drugs
Apr 19, 2024, 07:31 |
Drugs
Joseph Steward: Boston Consulting Group‘s overview of ADCs currently in clinical development
Joseph Steward, Freelance Medical and Scientific Writer, shared on LinkedIn: “Antibody-drug conjugates (ADCs) have become…
Apr 19, 2024, 07:07 |
Drugs
Robin Zon: We had a very constructive discussion regarding drug shortages, cancer research and CONNECT legislation
Robin Zon, President Elect at ASCO and Chair of South Bend Medical Foundation, posted on…
Apr 19, 2024, 06:25 |
Drugs
,
Opinion
Rami Manochakian: The Drug Shortage crisis
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: "The Drug…
Apr 18, 2024, 12:54 |
Drugs
Volastra Therapeutics dosed the first ovarian cancer patient in a Phase 1b clinical trial for sovilnesib
Volastra Therapeutics shared a post on LinkedIn: "We are proud to announce that we dosed the…
Apr 17, 2024, 19:06 |
Drugs
New research from Dr. Jung-Min Lee has identified a potential drug to treat ovarian cancers - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "Milestones Monday: Ovarian cancer is the most lethal…
Apr 17, 2024, 14:12 |
Drugs
Thomas LeBlanc: Cancer patients cannot afford to delay treatment due to drug shortages
Thomas LeBlanc, Chief Patient Experience and Safety Officer at Duke Cancer Institute, shared on X/Twitter:…
Apr 17, 2024, 11:33 |
Drugs
Tanja Obradovic: What can we expect from antibody-drug conjugates (ADCs) in advanced ovarian cancer beyond Mirvetuximab?
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “What…
Apr 16, 2024, 12:58 |
Drugs
Emre Yekedüz: A retrospective study from Gustave Roussy
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer…
Apr 16, 2024, 11:25 |
Drugs
Piotr Wysocki: Adjuvant olaparib improves outcomes of breast cancer patients with germinal BRCA1/2 mutations at the cost of slightly decreased quality of life
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 16, 2024, 07:45 |
Drugs
Arndt Vogel: Access to new medicines in Canada, Europe, and the United States
Arndt Vogel shared on X/Twitter: "Access to new medicines in Canada, Europe, and the United States:…
3
4
5
6
7
All:
303
Posts:
41 - 50
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube